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LIOMAS are the most common primary brain tumors.
Many of these neoplasms, especially astrocytic and
oligodendroglial lesions, are characterized by dif-
fuse infiltrative growth in the preexisting brain tissue, ac-
companied by a more solid component of variable size and
intensity.32 The diffuse infiltrative growth pattern hampers
not only radiological/neuroimaging detection and delinea-
tion but also topical curative treatment (for example, by sur-
gery or irradiation) of these tumors. Gliomatosis cerebri is a
rare neoplasm, defined by the WHO-2000 classification of
tumors of the nervous system13 as a diffuse glial tumor infil-
trating the brain extensively, involving more than two lobes,
frequently bilaterally, and often extending to infratentorial
structures. In some cases, even the entire neural axis might
be involved.5 The prognosis in patients with gliomatosis
cerebri is usually poor; according to the WHO-2000 clas-
sification, gliomatosis cerebri is considered to represent
Grade III malignancy, although long-term survival has been
reported in some individuals.
Clinically the presentation of gliomatosis cerebri varies
widely, ranging from symptoms mimicking vascular dis-
ease to mental illness or epileptic manifestations.1,28 Unfor-
tunately CT and MR imaging characteristics are also non-
specific for this condition, thus making a clinical diagnosis
difficult. Histopathologically, one often observes a diffuse
and sometimes symmetrical cellular infiltration of glial cells
in the preexisting brain tissue with relative preservation of
the neuronal architecture.
That a gliomatosis cerebri does not usually exhibit en-
hancement on CT or MR imaging suggests that angiogene-
sis may not be one of its features. This is in contrast with the
notion that most tumors, probably also including high-grade
gliomas, require angiogenesis for their growth.8,23 To es-
tablish the role of neovasularization in gliomatosis cerebri,
we performed computerized image analyses to assess ves-
sel density and diameter in histological sections of multiple
pathological and normal areas of a brain in which a glio-
matosis cerebri was present. In addition, the presence of
BBB characteristics was investigated in these areas by us-
ing immunohistochemical markers (Glut-1 and PgP). To
our knowledge, this is the first quantitative study of the vas-
cularity of gliomatosis cerebri. Analysis of our results indi-
cates that angiogenesis was absent in the gliomatosis ce-
rebri, suggesting that tumor growth in these neoplasms is
supported by cooptation of the existing vasculature and not
by the formation of new vessels.
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Object. Gliomas are the most common primary brain tumors, many of which (especially astrocytic and oligodendroglial
neoplasms) are characterized by diffuse infiltrative growth in the preexisting brain tissue. Gliomatosis cerebri is a rare glial
tumor and represents an extreme example of such diffuse infiltrative growth. This growth pattern not only hampers cura-
tive treatment but also allows for vessel cooptation rather than tumor angiogenesis as a way of vessel recruitment by the
tumor tissue. The goal of this study was to establish the extent to which tumor angiogenesis occurs in gliomatosis cerebri. 
Methods. Computerized image analysis was performed to assess quantitatively two microvascular parameters (vessel
density and diameter) in different areas of a brain harboring a gliomatosis cerebri. These regions were the cerebral white
and gray matter in which there was a diffuse infiltrative tumor, cerebral white and gray matter in which there was a more
compact growth pattern of tumor cells, and normal cerebral white and gray matter. In addition, the authors performed im-
munohistochemical stainings for blood–brain barrier (BBB) characteristics (Glut-1 and PgP) on samples obtained in these
different areas.
The results of the quantitative analysis strongly indicated that in gliomatosis cerebri tumor, angiogenesis was completely
absent, a finding that is corroborated by the fact that the microvasculature in gliomatosis cerebri persists in exhibiting im-
munohistochemical characteristics of the BBB.
Conclusions. The results of this study may help resolve the difficulties in radiological detection and delineation of the
diffuse infiltrative part of glial brain tumors and put the expectations for antiangiogenic treatment of such tumors into per-
spective.
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Abbreviations used in this paper: BBB = blood–brain barrier;
CT = computerized tomography; MR = magnetic resonance;
VEGF = vascular endothelial growth factor; WHO = World Health
Organization.
10_05_JNS.2  9/19/05  11:41 AM  Page 702
Materials and Methods
Clinical Data
This 68-year-old man presented to the hospital with a 1-month
history of phatic disturbances and cognitive dysfunction. His fam-
ily reported that his complaints began suddenly. His medical history
was unremarkable except for a 3-year history of atrial fibrillation.
Neurological examination revealed a Mini-Mental State score of 18,
a regular pulse, mild right hemiparesis (including a central facial pa-
resis), and mild disturbance in word fluency and comprehension.
Transverse CT scanning revealed a large subcortical hypodense area
in the left cerebral hemisphere (Fig. 1a). Transverse T2-weighted MR
imaging demonstrated a large subcortical area of increased signal in-
tensity in this hemisphere (Fig. 1b and c), but contrast enhancement
was absent. Before the neurological workup could be finished, the
patient was admitted to a nursing home and lost to follow up for 4
months. When he was readmitted to the hospital, the patient suffered
from mutism and quadriparesis with increased, generalized muscle
rigidity and bilateral impaired reflexes. Transverse CT scanning now
revealed increased hypodensity of the white matter in the left ce-
rebral hemisphere, as well as in the right hemisphere, still without
contrast enhancement (Fig. 1d). A pulmonary infection developed
and the patient died a few days after readmission. Autopsy examina-
tion (including the brain) indicated that pneumonia was the cause of
death. 
Neuropathological Findings
The brain weight (1410 g) was within normal range. Attached to
the dura mater, a small parasagittal meningioma (maximal diameter
1.5 cm) was found in the parietooccipital region. The brain showed
some signs of swelling (moderate flattening of cerebral gyri, as well
as moderate prominence of parahippocampal gyri and cerebellar ton-
sils), but no evidence of herniation. The brain swelling might have
been caused by hypoxic damage in an agonal phase rather than by
the brain tumor, especially because CT scans obtained several days
prior to death revealed no brain swelling. After formalin fixation, the
brain was cut into 1-cm-thick slices. On the cut surface, the white
matter in the left frontal, parietal, and occipital lobes showed wide-
spread, poorly demarcated softening with dispersed rarefaction. In
the basal cortex of the left occipital lobe, we observed a more cir-
cumscribed, small lesion (maximum dimension 1 cm) exhibiting
granular texture. Multiple samples were acquired of both cerebral
hemispheres, the cerebellum, and the brainstem, and embedded in
paraffin; 4-mm histological sections were cut and stained with H &
E and a combined Luxol fast blue–H & E staining. Microscopically,
the more circumscribed occipital lobe lesion consisted of densely
packed, relatively small, elongated cells with oval or elongated nu-
clei, moderate nuclear pleomorphism, little eosinophilic cytoplasm,
and focally high mitotic activity. In the periphery of this lesion, peri-
vascular cuffs of a highly cellular tumor were found. In the left fron-
tal, parietal, and occipital lobes, as well as in the right half of the
corpus callosum, extremely extensive, diffuse infiltrative growth of
tumor cells was found in both gray and white matter, accompanied
by rarefaction of the preexisting white matter, some reactive astro-
cytosis, and occasional macrophages. Necrosis and florid micro-
vascular proliferation were absent. In line with the definition of the
WHO-2000 classification,13 the tumor in this case was diagnosed as
a gliomatosis cerebri.
Quantitative Analysis
Quantitative analysis of the the microvasculature in histologically
normal and pathological brain tissue obtained in this patient was per-
formed as previously described.33,34 In short, histological sections
of paraffin-embedded tissue samples were immunohistochemically
stained with a monoclonal anti–collagen IV antibody (Sigma Chem-
ical Co., St. Louis, MO), resulting in clear-cut demarcation of the
intracerebral microvasculature. Computerized quantitative analysis
was performed using the VidasPlus system (Kontron GmbH, Ech-
ing, Germany). Microscopic fields measuring 400 3 425 mm were
selected from the following areas of the cerebrum for further micro-
vasculature quantitative analysis: normal neocortex (number of ana-
lyzed microscopic fields, 15); normal white matter (number of mi-
croscopic fields, 30); neocortex with diffuse infiltrative tumor from
the left frontal lobe (convex and basal areas) and from the basal part
of the occipital lobe (number of microscopic fields, 43); white mat-
ter with diffuse infiltrative tumor from the left frontal, left occipital,
and right frontal lobes (number of microscopic fields, 97); neocortex
with compact tumor from the basal area of the left occipital lobe
(number of microscopic fields, 28); and white matter with compact
tumor from the basal area of the left occipital lobe (number of micro-
scopic fields, eight). In each microscopic field the number of sepa-
rate vascular profiles was assessed. Additionally, the diameter of
each individual vascular profile was measured. Statistical evaluation
was performed using SPSS 10.0 for Windows (SPSS, Inc., Chicago,
IL). A one-way analysis of variance was used to study the differ-
ences among the aforementioned areas. Because the Levene test
showed an inhomogeneity of variances (p , 0.001), Tamhane post
hoc tests were used in the analysis of variance. Finally, histological
sections of paraffin-embedded tissue samples were immunohisto-
chemically stained for BBB markers with the monoclonal antibodies
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FIG. 1. a: Transverse CT scan demonstrating a large subcortical hypodense area in the left hemisphere on first admis-
sion to the hospital. b and c: Transverse T1-weighted Gd-enhanced and T2-weighted MR images revealing a large subcor-
tical area in the left cerebral hemisphere that is hypointense but does not enhance after contrast administration (b), and ex-
hibits increased signal on a T2-weighted sequence (c). d: Transverse CT scan obtained 4 months after initial admission,
demonstrating increased hypodensity in not only the left but also the right cerebral hemisphere (again without contrast en-
hancement). Arrowheads indicate the pathological areas; R = frontal right side.
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Glut-1 and PgP (Dako, Glostrup, Denmark) after standard antigen
retrieval (citrate buffer and microwave) as previously described.16
Results
The vessel number in tumor-infiltrated white matter and
cortex was equal to or significantly lower than in their nor-
mal brain counterparts (Fig. 2). The vessel diameter in tu-
mor-infiltrated areas tended to be somewhat higher than in
normal brain tissue, but this difference did not reach statis-
tical significance. The results of the quantitative analysis are
depicted in Fig. 2. Examples of the microvascular parame-
ters in different tumor areas are shown in Fig. 3. In both nor-
mal and tumor-infiltrated cerebral cortex and white mat-
ter, almost all microvessels stained positively for the BBB
markers Glut-1 and PgP (Fig. 4).
Discussion 
The role of angiogenesis in the growth and malignant
progression of tumors in general,8 and in malignant gliomas
in particular, has gained considerable attention in the last
decade.23 Endothelial/microvascular proliferation and con-
trast enhancement as signs of neovascularization, however,
are rarely mentioned in conjunction with gliomatosis cere-
bri. Gliomatosis cerebri is an entity known for its extreme-
ly diffuse infiltration of neoplastic cells in the brain tissue,
often with minimal destruction of preexisting structures.3,9,
13,30 In fact, such diffuse infiltrative growth may very well
allow the tumor to recruit vessels by cooptation rather than
angiogenesis. The main purpose of our examination was
to evaluate the extent of angiogenesis in gliomatosis cere-
bri. To our knowledge, this is the first report in which a sys-
tematic study of the vascularization in gliomatosis cerebri is
presented.
Our quantitative vascular analysis confirmed that, in con-
trast to other high-grade gliomas,34 in our patient with glio-
matosis cerebri, neovascularization was not a characteristic
feature. This finding indicates that tumor progression was
not facilitated by the development of a neovascular bed;
rather, the mechanism of migration and infiltration into the
preexisting brain parenchyma allowed tumor growth. This
phenomenon has recently been described as “coöption” of
the preexisting vascular bed.18,25 Interestingly, it was not on-
ly described in the brain parenchyma11,14–17,21,26 but also in the
skin,6 lung,20,22 and liver.29,31
The presence of vessel cooptation, the absence of neovas-
H. Bernsen, et al.
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FIG. 2. Box plots representing median (transverse line in box),
75th, and 25th percentile (upper and lower end of boxes) and high-
est and lowest values (upper and lower end of lines) for vessel num-
ber and diameter in the following cerebral areas: normal white mat-
ter (WM), white matter with diffuse infiltrative tumor (WMdt),
white matter with compact tumor (WMct), normal neocortex (CX),
neocortex with diffuse infiltrative tumor (CXdt), and neocortex with
compact tumor (CXct). Note that in both white matter and cortex,
the presence of diffuse or compact tumor is associated with a de-
crease, rather than increase, in vessel number, whereas the vessel di-
ameter tends to be somewhat higher in tumor-infiltrated areas. 
FIG. 3. Photomicrographs providing examples of quantitative
analysis of microvascular parameters in cerebral white matter and
cortex with diffuse infliltrative or more compact tumor growth. The
images show the immunohistochemical staining for collagen Type
IV, which highlights the basement membrane of the microvascula-
ture and which was used for computerized image analysis. Original
magnification 3 100.
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cularization, and the apparently limited changes to the pre-
existing, incorporated vessels in gliomatosis cerebri explain
why these lesions do not enhance on MR images after con-
trast administration.35 Because both clinical symptoms and
neuroradiological findings are often nonspecific, histologi-
cal examination is generally required to establish the nature
of this condition.12 Often considered are demyelinating dis-
eases, inflammatory or infectious processes (for example,
progressive multifocal leukencephalopathy), and ischemic
changes or leukodystrophia.24
Vascular leakage and neovascularization are VEGF-de-
pendent processes.7 In a mouse model with intracerebral hu-
man melanoma xenografts, we recently showed that even
using high-resolution (7-tesla) MR imaging, VEGF-nega-
tive brain metastases are hardly detectable.17 Histologically,
such tumors grow by cooptation of the preexisting vascu-
lature.15,16 When such tumors were engineered to produce
VEGF, however, they were easily demonstrated on MR im-
ages as contrast-enhancing tumors.15,17 On MR imaging,
anaplastic astrocytoma and glioblastoma multiforme typi-
cally exhibit areas of contrast enhancement, which corre-
spond to areas of vascular changes (vasodilation or glomer-
uloid microvascular proliferation) at the histological level.
Such changes have been shown to be VEGF dependent.10
Interestingly, in experimental glioblastoma multiforme
models, the blockade of vascular changes by anti-VEGF
therapy resulted in increased vessel cooptation by the tu-
mor.14,26 In our murine model of intracerebral human mela-
noma metastases, we also recently demonstrated that VEGF
blockade leads to a cooptative phenotype and makes their
MR imaging detection difficult.19
To date, the treatment of gliomatosis cerebri usually con-
sists of external radiotherapy and corticosteroid therapy.2,12
Radiation therapy may be useful in some patients with glio-
matosis cerebri,4 although the duration of effects is limited.2
Recently, Sanson and colleagues27 reported an effect after
temozolomide and procarbazine-lomustine-vincristine che-
motherapy, especially in patients with slow-growing glio-
matosis cerebri.
Conclusions
Based on our present and previous findings we conclude
that, although MR imaging–documented contrast enhance-
ment of parts of brain tumors may be used as an argument
for responsiveness to antiangiogenic therapy, gliomatosis
cerebri and the nonenhancing portion of other diffuse infil-
trative gliomas are very unlikely to respond to such therapy. 
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